Search Results - "Zou, Xiaomeng"

Cardiovascular Toxicity With PD-1/PD-L1 Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis by Liu, Surui, Gao, Wei, Ning, Yan, Zou, Xiaomeng, Zhang, Weike, Zeng, Liangjie, Liu, Jie

“…Background PD-1/PD-L1 inhibitors have significantly improved the outcomes of those patients with various malignancies. However, the incidence of adverse events…”
Get full text

Posterior reversible encephalopathy syndrome after anlotinib treatment for small cell lung cancer: A case report and literature review by Zou, Xiaomeng, Zhou, Peng, Lv, Wei, Liu, Chuanyong, Liu, Jie

“…Anlotinib is an oral multi-targeted tyrosine kinase inhibitor as a third-line and subsequent treatment for patients with small cell lung cancer (SCLC) in…”
Get full text

PFP@PLGA/Cu12Sb4S13-mediated PTT ablates hepatocellular carcinoma by inhibiting the RAS/MAPK/MT-CO1 signaling pathway by Dong, Tianxiu, Jiang, Jian, Zhang, Hao, Liu, Hongyuan, Zou, Xiaomeng, Niu, Jiamei, Mao, Yingxuan, Zhu, Mingwei, Chen, Xi, Li, Zizhuo, Chen, Yaodong, Shi, Chunying, Yang, Xiuhua

“…Hepatocellular carcinoma (HCC) is one of the most malignant tumors in the world, and patients with HCC face a poor prognosis. The conventional therapeutic…”
Get full text

Correction to: PFP@PLGA/Cu12Sb4S13‑mediated PTT ablates hepatocellular carcinoma by inhibiting the RAS/MAPK/MT‑CO1 signaling pathway by Dong, Tianxiu, Jiang, Jian, Zhang, Hao, Liu, Hongyuan, Zou, Xiaomeng, Niu, Jiamei, Mao, Yingxuan, Zhu, Mingwei, Chen, Xi, Li, Zizhuo, Chen, Yaodong, Shi, Chunying, Yang, Xiuhua

Get full text

CCL2-targeted ginkgolic acid exerts anti-glioblastoma effects by inhibiting the JAK3-STAT1/PI3K-AKT signaling pathway by Chen, Xi, Zhu, Mingwei, Zou, Xiaomeng, Mao, Yingxuan, Niu, Jiamei, Jiang, Jian, Dong, Tianxiu, Shi, Ying, Yang, Xiuhua, Liu, Pengfei

“…Glioblastoma (GBM) with aggressive nature and poor prognosis has become the most common intracranial tumor. Most clinical chemotherapeutic drugs fail to…”
Get full text

Multifunctional Drug-Loaded Phase-Change Nanoparticles Inhibit the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Affecting the Activity of Activated Hepatic Stellate Cells by Zou, Xiaomeng, Li, Tiantian, Mao, Yingxuan, Zhu, Mingwei, Chen, Xi, Niu, Jiamei, Dong, Tianxiu, Jiang, Jian, Yang, Xiuhua

“…Objectives. Preparation of a multifunctional drug-loaded phase-change nanoparticle (NP), pirfenidone perfluoropentane liposome NPs (PPL NPs), and combined with…”
Get full text

Triptonide inhibits growth and metastasis in HCC by suppressing EGFR/PI3K/AKT signaling by Zhang, Hao, Mao, Yingxuan, Zou, Xiaomeng, Niu, Jiamei, Jiang, Jian, Chen, Xi, Zhu, Mingwei, Yang, Xiuhua, Dong, Tianxiu

“…Liver cancer represents one of the deadliest cancers, with a rising incidence worldwide. Triptonide is found in the traditional Chinese medicinal plant…”
Get more information

Correction to: PFP@PLGA/Cu 12 Sb 4 S 13 ‑mediated PTT ablates hepatocellular carcinoma by inhibiting the RAS/MAPK/MT‑CO1 signaling pathway by Dong, Tianxiu, Jiang, Jian, Zhang, Hao, Liu, Hongyuan, Zou, Xiaomeng, Niu, Jiamei, Mao, Yingxuan, Zhu, Mingwei, Chen, Xi, Li, Zizhuo, Chen, Yaodong, Shi, Chunying, Yang, Xiuhua

Get full text

PFP@PLGA/Cu 12 Sb 4 S 13 -mediated PTT ablates hepatocellular carcinoma by inhibiting the RAS/MAPK/MT-CO1 signaling pathway by Dong, Tianxiu, Jiang, Jian, Zhang, Hao, Liu, Hongyuan, Zou, Xiaomeng, Niu, Jiamei, Mao, Yingxuan, Zhu, Mingwei, Chen, Xi, Li, Zizhuo, Chen, Yaodong, Shi, Chunying, Yang, Xiuhua

“…Hepatocellular carcinoma (HCC) is one of the most malignant tumors in the world, and patients with HCC face a poor prognosis. The conventional therapeutic…”
Get full text

Posterior reversible encephalopathy syndrome after anlotinib treatment for small cell lung cancer: A case report and literature review by Zou, Xiaomeng, Zhou, Peng, Lv, Wei, Liu, Chuanyong, Liu, Jie

Get full text